Amgen (AMGN) Tops Q4 EPS by 18c
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $365.96 -0.09%
Revenue Growth %: +2.7%
Financial Fact:
Research and development: 990M
Today's EPS Names:
DIT, AMC, DPZ, More
Revenue Growth %: +2.7%
Financial Fact:
Research and development: 990M
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.64, $0.18 better than the analyst estimate of $3.46. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.06 billion.
GUIDANCE:
Amgen sees FY2020 EPS of $14.85-$15.60, versus the consensus of $16.14. Amgen sees FY2020 revenue of $25-25.6 billion, versus the consensus of $25.5 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA expects Apple to top analyst expectations on July 30
- Golden State Water seeks CPUC approval for $5.25M Norwalk system buy
- Dynex Capital (DX) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
